Literature DB >> 27719984

Imaging of Idiopathic Pulmonary Fibrosis.

Joanna E Kusmirek1, Maria Daniela Martin2, Jeffrey P Kanne2.   

Abstract

Idiopathic interstitial pneumonias are a heterogeneous group of diffuse lung diseases characterized by distinct clinicopathologic entities with the usual interstitial pneumonia (UIP) being the most common. The pattern of UIP can be seen in idiopathic pulmonary fibrosis (IPF) as well as in secondary causes, most commonly in connective tissue diseases. IPF is usually progressive and associated with a very poor prognosis, and newer therapies pose a risk of serious complications; therefore, diagnostic certainty is crucial. This article reviews the radiologic findings in UIP with clinical correlation and histopathologic features along with its significance for prognosis and patients monitoring.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HRCT; Idiopathic interstitial pneumonia; Idiopathic pulmonary fibrosis; Usual interstitial pneumonia

Mesh:

Year:  2016        PMID: 27719984     DOI: 10.1016/j.rcl.2016.05.004

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  3 in total

Review 1.  Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics.

Authors:  Bruno Hochhegger; Edson Marchiori; Matheus Zanon; Adalberto Sperb Rubin; Renata Fragomeni; Stephan Altmayer; Carlos Roberto Ribeiro Carvalho; Bruno Guedes Baldi
Journal:  Clinics (Sao Paulo)       Date:  2019-02-04       Impact factor: 2.365

Review 2.  Imaging Review of the Lung Parenchymal Complications in Patients with IPF.

Authors:  Elisa Baratella; Ilaria Fiorese; Cristina Marrocchio; Francesco Salton; Maria Assunta Cova
Journal:  Medicina (Kaunas)       Date:  2019-09-20       Impact factor: 2.430

Review 3.  Fibrosis imaging: Current concepts and future directions.

Authors:  Maike Baues; Anshuman Dasgupta; Josef Ehling; Jai Prakash; Peter Boor; Frank Tacke; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2017-11-20       Impact factor: 15.470

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.